AstraZeneca : AZN

All AstraZeneca Articles

218 Articles

Lee Jackson | Dec 14, 2018 at 9:14 AM EST

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline,…

Jon C. Ogg | Nov 19, 2018 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More

Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is…

Jon C. Ogg | Aug 16, 2018 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AVEO, Boeing, Canopy Growth, Coty, Kimberly-Clark, Lululemon, Macy’s, Sysco, Teladoc and More

The include top analyst upgrades, downgrades and initiations seen from Thursday AVEO Pharmaceuticals, Boeing, Canopy Growth, Coty, Kimberly-Clark, Lululemon Athletica,…

Lee Jackson | May 14, 2018 at 8:00 AM EDT

5 Merrill Lynch Equity Income Stocks With Huge Total Return Potential

These five top growth companies are all rated Buy and pay outstanding dividends, and they have good growth prospects.

Lee Jackson | Mar 19, 2018 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical, Unilever and More

Monday’s top analyst upgrades, downgrades and initiations include AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical and Unilever.

Jon C. Ogg | Dec 29, 2017 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: American Water Works, JB Hunt, Ford, GM, AstraZeneca and More

The top analyst upgrades, downgrades and other research calls from Friday include American Water Works, JB Hunt, Ford, General Motors…

Lee Jackson | Sep 22, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Alcoa, American Airlines, Equifax, Mindbody, Tiffany, Tyler Technologies and More

The top analyst upgrades, downgrades and other research calls from Friday include Alcoa, American Airlines, Equifax, Mindbody, Tiffany and Tyler…

Jon C. Ogg | Sep 13, 2017 at 7:15 AM EDT

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown…

Jon C. Ogg | Sep 7, 2017 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Arch Coal, Editas, FireEye, Generac, NextEra, Under Armour and More

The top analyst upgrades, downgrades and other research calls from Thursday include Arch Coal, Editas Medicine, FireEye, Generac, NextEra Energy…

Jon C. Ogg | Sep 1, 2017 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Ambarella, Apple, Campbell Soup, Gap, Kinross Gold, Lululemon, Palo Alto Networks and More

The top analyst upgrades, downgrades and other research calls from Friday include Ambarella, Apple, Campbell Soup, Gap, Kinross Gold, Lululemon Athletica…

Chris Lange | May 3, 2017 at 11:25 AM EDT

Pieris Pharma Soars on AstraZeneca Collaboration

Shares of Pieris Pharmaceuticals saw perhaps one of the biggest gains on Wednesday after the company announced a critical collaboration…

Jon C. Ogg | Apr 10, 2017 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Canada Goose, Cypress Semi, Ralph Lauren, Sunoco, Tesla, Wells Fargo and Many More

The top analyst upgrades, downgrades and initiations seen on Monday include Canada Goose, Cypress Semiconductor, Ralph Lauren, Sunoco, Tesla and…

Jon C. Ogg | Apr 7, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AECOM, Apache, Panera, Sunoco, Wal-Mart and Many More

The top analyst upgrades, downgrades and initiations seen from Friday include AECOM, Apache, Panera, Sunoco and Wal-Mart.

Lee Jackson | Apr 5, 2017 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: AstraZeneca, Hasbro, Roche, Peabody Energy, Suncor, Wynn and More

Wednesday’s top analyst upgrades, downgrades and initiations included AstraZeneca, Hasbro, Roche, Peabody Energy, Suncor and Wynn Resorts,

Chris Lange | Feb 16, 2017 at 12:05 PM EST

Why This FDA Approval for Valeant Is Not as Good as First Thought

Valeant Pharmaceuticals received a key FDA approval early on Thursday, but it seems to be a mixed blessing.

1 … 4 5 6 7 8 … 15

AstraZeneca : AZN

All AstraZeneca Articles

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More

Top Analyst Upgrades and Downgrades: AVEO, Boeing, Canopy Growth, Coty, Kimberly-Clark, Lululemon, Macy’s, Sysco, Teladoc and More

5 Merrill Lynch Equity Income Stocks With Huge Total Return Potential

Top Analyst Upgrades and Downgrades: AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical, Unilever and More

Top Analyst Upgrades and Downgrades: American Water Works, JB Hunt, Ford, GM, AstraZeneca and More

Top Analyst Upgrades and Downgrades: Alcoa, American Airlines, Equifax, Mindbody, Tiffany, Tyler Technologies and More

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Top Analyst Upgrades and Downgrades: Arch Coal, Editas, FireEye, Generac, NextEra, Under Armour and More

Top Analyst Upgrades and Downgrades: Ambarella, Apple, Campbell Soup, Gap, Kinross Gold, Lululemon, Palo Alto Networks and More

Pieris Pharma Soars on AstraZeneca Collaboration

Top Analyst Upgrades and Downgrades: Canada Goose, Cypress Semi, Ralph Lauren, Sunoco, Tesla, Wells Fargo and Many More

Top Analyst Upgrades and Downgrades: AECOM, Apache, Panera, Sunoco, Wal-Mart and Many More

Top Analyst Upgrades and Downgrades: AstraZeneca, Hasbro, Roche, Peabody Energy, Suncor, Wynn and More

Why This FDA Approval for Valeant Is Not as Good as First Thought

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

AstraZeneca : AZN

All AstraZeneca Articles

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More

Top Analyst Upgrades and Downgrades: AVEO, Boeing, Canopy Growth, Coty, Kimberly-Clark, Lululemon, Macy’s, Sysco, Teladoc and More

5 Merrill Lynch Equity Income Stocks With Huge Total Return Potential

Top Analyst Upgrades and Downgrades: AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical, Unilever and More

Top Analyst Upgrades and Downgrades: American Water Works, JB Hunt, Ford, GM, AstraZeneca and More

Top Analyst Upgrades and Downgrades: Alcoa, American Airlines, Equifax, Mindbody, Tiffany, Tyler Technologies and More

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Top Analyst Upgrades and Downgrades: Arch Coal, Editas, FireEye, Generac, NextEra, Under Armour and More

Top Analyst Upgrades and Downgrades: Ambarella, Apple, Campbell Soup, Gap, Kinross Gold, Lululemon, Palo Alto Networks and More

Pieris Pharma Soars on AstraZeneca Collaboration

Top Analyst Upgrades and Downgrades: Canada Goose, Cypress Semi, Ralph Lauren, Sunoco, Tesla, Wells Fargo and Many More

Top Analyst Upgrades and Downgrades: AECOM, Apache, Panera, Sunoco, Wal-Mart and Many More

Top Analyst Upgrades and Downgrades: AstraZeneca, Hasbro, Roche, Peabody Energy, Suncor, Wynn and More

Why This FDA Approval for Valeant Is Not as Good as First Thought

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

Featured Reads

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It